chr14-61996251-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001367656.1(SYT16):āc.232C>Gā(p.Gln78Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001367656.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SYT16 | NM_001367656.1 | c.232C>G | p.Gln78Glu | missense_variant | 3/8 | ENST00000683842.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SYT16 | ENST00000683842.1 | c.232C>G | p.Gln78Glu | missense_variant | 3/8 | NM_001367656.1 | P1 | ||
SYT16 | ENST00000568344.5 | c.232C>G | p.Gln78Glu | missense_variant | 1/6 | 1 | P1 | ||
SYT16 | ENST00000636133.1 | c.193+25940C>G | intron_variant | 5 | |||||
SYT16 | ENST00000555409.1 | c.232C>G | p.Gln78Glu | missense_variant, NMD_transcript_variant | 1/7 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461344Hom.: 0 Cov.: 58 AF XY: 0.00 AC XY: 0AN XY: 726944
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2023 | The c.232C>G (p.Q78E) alteration is located in exon 1 (coding exon 1) of the SYT16 gene. This alteration results from a C to G substitution at nucleotide position 232, causing the glutamine (Q) at amino acid position 78 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.